WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Wednesday. The stock traded as high as $28.6899 and last traded at $28.6899, with a volume of 4909 shares changing hands. The stock had previously closed at $27.67.
Analysts Set New Price Targets
Separately, Zacks Research downgraded WuXi AppTec from a “strong-buy” rating to a “hold” rating in a report on Monday. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, WuXi AppTec presently has a consensus rating of “Moderate Buy”.
Read Our Latest Analysis on WUXAY
WuXi AppTec Stock Performance
About WuXi AppTec
WuXi AppTec is a contract research, development and manufacturing organization (CRDMO) that provides services to pharmaceutical, biotechnology and medical-device companies. Its offerings span the drug-development process, including early-stage discovery, medicinal and synthetic chemistry, biology research, analytical testing, preclinical studies, clinical research support, process development and commercial manufacturing.
The company supports a broad range of therapeutic programs, with capabilities covering small-molecule drugs, biologics, chemical and pharmaceutical products, and cell and gene therapies.
See Also
- Five stocks we like better than WuXi AppTec
- Wall Street Left Software for Dead: 4 Stocks Institutions Are Buying Back
- Alphabet and Unity Level Up Game Development
- Applied Digital’s Hidden Moat Could Unlock Massive Upside
- Want Private-Market Access to Kalshi and Polymarket? Try This ETF
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
